000			01364 a2200361 4500
005			20250512031939.0
264		0	_c19870211
008			198702s 0 0 eng d
022			_a0196-9781
024	7		_a10.1016/0196-9781(86)90105-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aTurner, J T
245	0	0	_aA fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29. _h[electronic resource]
260			_bPeptides _c
300			_a849-54 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdenocarcinoma _xmetabolism
650	0	4	_aAdenylyl Cyclases _xmetabolism
650	0	4	_aBinding, Competitive
650	0	4	_aCell Line
650	0	4	_aCell Membrane _xmetabolism
650	0	4	_aColonic Neoplasms _xmetabolism
650	0	4	_aHumans
650	0	4	_aKinetics
650	0	4	_aPeptide Fragments _xpharmacology
650	0	4	_aReceptors, Gastrointestinal Hormone _xdrug effects
650	0	4	_aReceptors, Vasoactive Intestinal Peptide
650	0	4	_aVasoactive Intestinal Peptide _xmetabolism
700	1		_aJones, S B
700	1		_aBylund, D B
773	0		_tPeptides _gvol. 7 _gno. 5 _gp. 849-54
856	4	0	_uhttps://doi.org/10.1016/0196-9781(86)90105-1 _zAvailable from publisher's website
999			_c3031640 _d3031640